Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality study.
We report the results of a randomized single-centre study designed to assess the effects of simvastatin on blood lipids, blood biochemistry, haematology and other measures of safety and tolerability in preparation for a large-scale multicentre mortality study. Six hundred and twenty-one individuals...
Main Authors: | Keech, A, Collins, R, MacMahon, S, Armitage, J, Lawson, A, Wallendszus, K, Fatemian, M, Kearney, E, Lyon, V, Mindell, J |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
1994
|
Registos relacionados
-
Absence of effect of simvastatin on the progression of lens opacities in a randomised placebo controlled study. Oxford Cholesterol Study Group.
Por: Harris, M, et al.
Publicado em: (1995) -
Absence of effects of prolonged simvastatin therapy on nocturnal sleep in a large randomized placebo-controlled study. Oxford Cholesterol Study Group.
Por: Keech, A, et al.
Publicado em: (1996) -
Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration. Oxford Cholesterol Study Group.
Por: Wardle, J, et al.
Publicado em: (1996) -
Randomized placebo-controlled study of the effects of simvastatin on haemostatic variables, lipoproteins and free fatty acids. The Oxford Cholesterol Study Group.
Por: Mitropoulos, K, et al.
Publicado em: (1997) -
Cholesterol and total mortality: need for larger trials.
Por: Collins, R, et al.
Publicado em: (1992)